Engagement of soluble resistance-related calcium binding protein (sorcin) with foot-and-mouth disease virus (FMDV) VP1 inhibits type I interferon response in cells

Veterinary Microbiology

Volumn 166, Issue 1-2, 2013, Pages 35-46

  Li, Xiaying ^a   Wang, Jianchang ^a   Liu, Jue ^b   Li, Zhonghua ^a   Wang, Yongqiang ^a   Xue, Yanfei ^a   Li, Xiaoqi ^a   Cao, Hong ^a   Zheng, Shijun J ^a,b  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b INSTITUTE OF PLANT AND ENVIRONMENT PROTECTION   (China)

Author keywords

FMDV; FMDV VP1; Immunosuppression; Interferon; SeV; Sorcin

Indexed keywords

INTERFERON; SHORT HAIRPIN RNA; SORCIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN EXPRESSION; VIRUS IDENTIFICATION;

FMDV; FMDV VP1; FOOT-AND-MOUTH DISEASE VIRUS; IMMUNOSUPPRESSION; INTERFERON; SENDAI VIRUS; SEV; SOLUBLE RESISTANCE-RELATED CALCIUM BINDING PROTEIN; SORCIN;

ANIMALS; CALCIUM-BINDING PROTEINS; CAPSID PROTEINS; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; HUMANS; INTERFERON TYPE I; PROTEIN BINDING; RNA, SMALL INTERFERING; SWINE; SWINE DISEASES;

ANIMALIA; FOOT-AND-MOUTH DISEASE VIRUS; SENDAI VIRUS; VESICULAR STOMATITIS VIRUS;

EID: 84880513672     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2013.04.028     Document Type: Article

References (55)

1. Alexandersen S., Zhang Z., Donaldson A.I. Aspects of the persistence of foot-and-mouth disease virus in animals - the carrier problem. Microbes. Infect. 2002, 4:1099-1110.
2. Anthony D.F., Beattie J., Paul A., Currie S. Interaction of calcium/calmodulin-dependent protein kinase II C with sorcin indirectly modulates ryanodine receptor function in cardiac myocytes. J. Mol. Cell. Cardiol. 2008, 43:492-503.
3. Bachrach H.L., Moore D.M., Mckercher P.D., Polatnick J. Immune and antibody-responses to an isolated capsid protein of foot-and-mouth-disease virus. J. Immunol. 1975, 115:1636-1641.
4. Bautista E.M., Ferman G.S., Golde W.T. Induction of lymphopenia and inhibition of T cell function during acute infection of swine with foot and mouth disease virus (FMDV). Vet. Immunol. Immunopathol. 2003, 92:61-73.
5. Berinstein A., Roivainen M., Hovi T., Mason P.W., Baxt B. Antibodies to the vitronectin receptor (integrin alpha V beta 3) inhibit binding and infection of foot-and-mouth disease virus to cultured cells. J. Virol. 1995, 69:2664-2666.
6. Bittle J.L., Houghten R.A., Alexander H., Shinnick T.M., Sutcliffe J.G., Lerner R.A., Rowlands D.J., Brown F. Protection against foot-and-mouth-disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide-sequence. Nature 1982, 298:30-33.
7. Brown F. New approaches to vaccination against foot-and-mouth-disease. Vaccine 1992, 10:1022-1026.
8. Carmody R.J., Maguschak K., Chen Y.H. A novel mechanism of nuclear factor-kappaB regulation by adenoviral protein 14.7K. Immunology 2006, 117:188-195.
9. Chen D., Li Z., Yang Q., Zhang J., Zhai Z., Shu H.B. Identification of a nuclear protein that promotes NF-kappaB activation. Biochem. Biophys. Res. Commun. 2003, 310:720-724.
10. Chen M., Lucas K.G., Akum B.F., Balasingam G., Stawicki T.M., Provost J.M., Riefler G.M., Jornsten R.J., Firestein B.L. A novel role for snapin in dendrite patterning: interaction with cypin. Mol. Biol. Cell 2005, 16:5103-5114.
11. Chinsangaram J., Koster M., Grubman M.J. Inhibition of L-deleted foot-and-mouth disease virus replication by alpha/beta interferon involves double-stranded RNA-dependent protein kinase. J. Virol. 2001, 75:5498-5503.
12. Chinsangaram J., Mason P.W., Grubman M.J. Protection of swine by live and inactivated vaccines prepared from a leader proteinase-deficient serotype A12 foot-and-mouth disease virus. Vaccine 1998, 16:1516-1522.
13. Chinsangaram J., Moraes M.P., Koster M., Grubman M.J. Novel viral disease control strategy: adenovirus expressing alpha interferon rapidly protects swine from foot-and-mouth disease. J. Virol. 2003, 77:1621-1625.
14. Chinsangaram J., Piccone M.E., Grubman M.J. Ability of foot-and-mouth disease virus to form plaques in cell culture is associated with suppression of alpha/beta interferon. J. Virol. 1999, 73:9891-9898.
15. Chou J.L., Huang C.L., Lai H.L., Hung A.C., Chien C.L., Kao Y.Y., Chern Y. Regulation of type VI adenylyl cyclase by Snapin, a SNAP25-binding protein. J. Biol. Chem. 2004, 279:46271-46279.
16. Collen T., Dimarchi R., Doel T.R. A T-cell epitope in Vp1 of foot-and-mouth-disease virus is immunodominant for vaccinated cattle. J. Immunol. 1991, 146:749-755.
17. de los Santos T., Botton S.D., Weiblen R., Grubman M.J. The leader proteinase of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response. J. Virol. 2006, 80:1906-1914.
18. de los Santos T., Segundo F.D.S., Grubman M.J. Degradation of nuclear factor kappa B during foot-and-mouth disease virus infection. J. Virol. 2007, 81:12803-12815.
19. Demarchi F., Gutierrez M.I., Giacca M. Human immunodeficiency virus type 1 Tat protein activates transcription factor NF-kappa B through the cellular interferon-inducible, double-stranded RNA-dependent protein kinase, PKR. J. Virol. 1999, 73:7080-7086.
20. Grubman M.J., Baxt B. Foot-and-mouth disease. Clin. Microbiol. Rev. 2004, 17:465.
21. Han K.J., Su X., Xu L.G., Bin L.H., Zhang J., Shu H.B. Mechanisms of the TRIF-induced interferon-stimulated response element and NF-kappaB activation and apoptosis pathways. J. Biol. Chem. 2004, 279:15652-15661.
22. Hansen C., Tarabykina S., la Cour J.M., Lollike K., Berchtold M.W. The PEF family proteins sorcin and grancalcin interact in vivo and in vitro. FEBS Lett. 2003, 545:151-154.
23. Helin E., Matikainen S., Julkunen L., Heino J., Hyypia T., Vainionpaa R. Measles virus enhances the expression of cellular immediate-early genes and DNA-binding of transcription factor AP-1 in lung epithelial A549 cells. Arch. Virol 2002, 147:1721-1732.
24. Hou F., Liu K., Shen T., Zhou B., Cao R., Li P., Chen P. Antiviral activity of rChIFN-alpha against vesicular stomatitis virus and Newcastle disease virus: a novel recombinant chicken interferon-alpha showed high antiviral activity. Res. Vet. Sci. 2011, 91:e73-e79.
25. Huang J., Teng L., Liu T., Li L., Chen D., Li F., Xu L.G., Zhai Z., Shu H.B. Identification of a novel serine/threonine kinase that inhibits TNF-induced NF-kappaB activation and p53-induced transcription. Biochem. Biophys. Res. Commun. 2003, 309:774-778.
26. Kleid D.G., Yansura D., Small B., Dowbenko D., Moore D.M., Grubman M.J., Mckercher P.D., Morgan D.O., Robertson B.H., Bachrach H.L. Cloned viral protein vaccine for foot-and-mouth-disease - responses in cattle and swine. Science 1981, 214:1125-1129.
27. Kowalik T.F., Wing B., Haskill J.S., Azizkhan J.C., Baldwin A.S., Huang E.S. Multiple mechanisms are implicated in the regulation of Nf-kappa-B activity during human cytomegalovirus-infection. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:1107-1111.
28. Laderach D., Compagno D., Danos O., Vainchenker W., Galy A. RNA interference shows critical requirement for NF-kappa B p50 in the production of IL-12 by human dendritic cells. J. Immunol. 2003, 171:1750-1757.
29. Landriscina M., Laudiero G., Maddalena F., Amoroso M.R., Piscazzi A., Cozzolino F., Monti M., Garbi C., Fersini A., Pucci P., Esposito F. Mitochondrial chaperone Trap1 and the calcium binding protein sorcin interact and protect cells against apoptosis induced by antiblastic agents. Cancer Res. 2010, 70:6577-6586.
30. Lea S., Hernandez J., Blakemore W., Brocchi E., Curry S., Domingo E., Fry E., Abughazaleh R., King A., Newman J., Stuart D., Mateu M.G. The structure and antigenicity of a type-C foot-and-mouth-disease virus. Structure 1994, 2:123-139.
31. Logan D., Abughazaleh R., Blakemore W., Curry S., Jackson T., King A., Lea S., Lewis R., Newman J., Parry N., Rowlands D., Stuart D., Fry E. Structure of a major immunogenic site on foot-and-mouth-disease virus. Nature 1993, 362:566-568.
32. Mason P.W., Grubman M.J., Baxt B. Molecular basis of pathogenesis of FMDV. Virus Res. 2003, 91:9-32.
33. Meyers M.B., Biedler J.L. Increased synthesis of a low-molecular weight protein in vincristine-resistant cells. Biochem. Biophys. Res. Commun. 1981, 99:228-235.
34. Meyers M.B., Pickel V.M., Sheu S.S., Sharma V.K., Scotto K.W., Fishman G.I. Association of sorcin with the cardiac ryanodine receptor. J. Biol. Chem. 1995, 270:26411-26418.
35. Meyers M.B., Puri T.S., Chien A.J., Gao T., Hsu P.H., Hosey M.M., Fishman G.I. Sorcin associates with the pore-forming subunit of voltage-dependent L-type Ca2+ channels. J. Biol. Chem. 1998, 273:18930-18935.
36. Meyers M.B., Schneider K.A., Spengler B.A., Chang T.D., Biedler J.L. Sorcin (V19), a soluble acidic calcium-binding protein overproduced in multidrug-resistant cells. Identification of the protein by anti-sorcin antibody. Biochem. Pharmacol. 1987, 36:2373-2380.
37. Mistry A.C., Mallick R., Frohlich O., Klein J.D., Rehm A., Chen G., Sands J.M. The UT-A1 urea transporter interacts with snapin, a SNARE-associated protein. J. Biol. Chem. 2007, 282:30097-30106.
38. Moraes M.P., Chinsangaram J., Brum M.C., Grubman M.J. Immediate protection of swine from foot-and-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine. Vaccine 2003, 22:268-279.
39. Neff S., Sa-Carvalho D., Rieder E., Mason P.W., Blystone S.D., Brown E.J., Baxt B. Foot-and-mouth disease virus virulent for cattle utilizes the integrin alpha(v)beta3 as its receptor. J. Virol. 1998, 72:3587-3594.
40. Pack-Chung E., Meyers M.B., Pettingell W.P., Moir R.D., Brownawell A.M., Cheng I., Tanzi R.E., Kim T.W. Presenilin 2 interacts with sorcin, a modulator of the ryanodine receptor. J. Biol. Chem. 2000, 275:14440-14445.
41. Palma J.P., Kwon D., Clipstone N.A., Kim B.S. Infection with Theiler's murine encephalomyelitis virus directly induces proinflammatory cytokines in primary astrocytes via NF-kappa B activation: Potential role for the initiation of demyelinating disease. J. Virol. 2003, 77:6322-6331.
42. Papi A., Johnston S.L. Rhinovirus infection induces expression of its own receptor intercellular adhesion molecule 1 (ICAM-1) via increased NF-kappa B-mediated transcription. J. Biol. Chem. 1999, 274:9707-9720.
43. Payvandi F., Amrute S., Fitzgerald-Bocarsly P. Exogenous and endogenous IL-10 regulate IFN-alpha production by peripheral blood mononuclear cells in response to viral stimulation. J. Immunol. 1998, 160:5861-5868.
44. Piccone M.E., Zellner M., Kumosinski T.F., Mason P.W., Grubman M.J. Identification of the active-site residues of the L proteinase of foot-and-mouth disease virus. J. Virol. 1995, 69:4950-4956.
45. Saiz M., Nunez J.I., Jimenez-Clavero M.A., Baranowski E., Sobrino F. Foot-and-mouth disease virus: biology and prospects for disease control. Microbes Infect. 2002, 4:1183-1192.
46. Sellers R.F. Multiplication, interferon production and sensitivity of virulent and attenuated strains of the virus of foot-and-mouth disease. Nature 1963, 198:1228-1229.
47. Sellers R.F., Mowat G.N., Bennett J.H., Barr D.A. The use of interferon production as a marker in the development of a modified strain of foot-and-mouth disease virus. Arch. Gesamte Virusforsch. 1968, 23:12-19.
48. Sharma P.K.S.K.G.C. Transcriptional regulation of human osteopontin promoter by histone deacetylase inhibitor, trichostatin A in cervical cancer cells. Mol. Cancer 2010, 9:178.
49. Shen A., Lei J., Yang E., Pei Y., Chen Y.C., Gong H., Xiao G., Liu F. Human cytomegalovirus primase UL70 specifically interacts with cellular factor Snapin. J. Virol. 2011, 85:11732-11741.
50. Summerfield A., Guzylack-Piriou L., Harwood L., McCullough K.C. Innate immune responses against foot-and-mouth disease virus: current understanding and future directions. Vet. Immunol. Immunopathol. 2009, 128:205-210.
51. Trottier M.D., Palian B.M., Reiss C.S. VSV replication in neurons is inhibited by type I IFN at multiple stages of infection. Virology 2005, 333:215-225.
52. Wang Y.Y., Liu L.J., Zhong B., Liu T.T., Li Y., Yang Y., Ran Y., Li S., Tien P., Shu H.B. WDR5 is essential for assembly of the VISA-associated signaling complex and virus-triggered IRF3 and NF-kappaB activation. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:815-820.
53. Wei S., Xu Y., Shi H., Wong S.H., Han W., Talbot K., Hong W., Ong W.Y. EHD1 is a synaptic protein that modulates exocytosis through binding to snapin. Mol. Cell. Neurosci. 2010, 45:418-429.
54. Zamparelli C., Macquaide N., Colotti G., Verzili D., Seidler T., Smith G.L., Chiancone E. Activation of the cardiac Na+-Ca2+ exchanger by sorcin via the interaction of the respective Ca2+-binding domains. J. Mol. Cell. Cardiol. 2010, 49:132-141.
55. Zhou Y., Xu Y.F., Tan Y.H., Qi J., Xiao Y., Yang C.Z., Zhu Z.P., Xiong D.S. Sorcin, an important gene associated with multidrug-resistance in human leukemia cells. Leuk. Res. 2006, 30:469-476.